跳至主要内容
临床试验/ACTRN12619000162112
ACTRN12619000162112尚未招募不适用

Evaluation of an eHealth type 2 diabetes risk reduction program for weight loss in women with a history of gestational diabetes

Professor Clare Collins0 个研究点目标入组 120 人开始时间: 2019年2月5日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Female

入选标准

  • had a gestational diabetes diagnosis in the last two years
  • - are at least 3 months post-partum
  • - have a Body Mass Index between 25 and 50 kg/m2

排除标准

  • - Are currently pregnant or trying to fall pregnant
  • - Have an orthopaedic and/or medical condition that may impact on your ability to safely participate in exercise or you have been diagnosed with diabetes (Type 1 or 2).
  • -Do not pass the pre-exercise screening tool (or you cannot obtain a Dr’s clearance if do you not pass the screener) for safety to engage in physical activity.
  • - have a smartphone, desktop computer, laptop or tablet computer and access to a broadband Internet connection suitable for conducting video calls (e.g. Skype).

研究者

发起方
Professor Clare Collins

相似试验

进行中(未招募)
不适用
Evaluation of a type 2 diabetes risk reduction program for weight loss in women with recent gestational diabetes.Type 2 diabetesGestational diabetesDiet and Nutrition - ObesityMetabolic and Endocrine - DiabetesReproductive Health and Childbirth - Fetal medicine and complications of pregnancyObesity
ACTRN12617001456347Professor Clare Collins42
招募中
2 期
Study to assess the Safety and Efficacy of Bacteriophage in the treatment of Diabetic foot infection.
CTRI/2023/11/059899TechnoPhage
进行中(未招募)
1 期
Evaluating Avelumab in combination with Cetuximab in Head and neck cancer (EACH)recurrent/metastatic head and neck squamous cell cancerMedDRA version: 20.0 Level: PT Classification code 10067821 Term: Head and neck cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10060121 Term: Squamous cell carcinoma of head and neck System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2017-003592-64-GBniversity College London130
进行中(未招募)
1 期
A Phase 2b Clinical Study to Evaluate the Safety and Efficacy of Topical Administration ofBacteriophage Therapy TP-102 in Patients with Diabetic Foot Infectio
CTIS2023-507716-13-00Technophage Investigacao E Desenvolvimento Em Biotecnologia S.A.80
进行中(未招募)
1 期
Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and BevacizumabColorectal Cancer
CTIS2023-505110-14-00AbbVie Deutschland GmbH & Co. KG206